Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $740.8600 (0.3%) ($710.2500 - $741.1300) on Fri. Nov. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 52 | Latest Price | $740.8600(0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(33%) SPLV(30%) IWD(29%) SPY(28%) | Factors Impacting REGN price | REGN will decline at least -1.49% in a week (0% probabilities). TBT(-13%) EDOC(-5%) VCSH(-3%) URA(-2%) VIXM(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $746.32(-0.73%) | 10 Day Moving Average | $742.54(-0.23%) | 20 Day Moving Average | $735.18(0.77%) | To recent high | -2.5% | To recent low | 29.1% | Market Cap | $78.552b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |